InterventionsReview

The Possible Hematological Cost of Metabolic Success: Do Incretin-Based Therapies Silently Trigger Anemia?

Figure 1. Proposed pathways that may contribute to hematological and nutritional changes during incretin-based therapy.
Open the figure at full size
Figure 1. Proposed pathways that may contribute to hematological and nutritional changes during incretin-based therapy.Proposed pathways that may contribute to hematological and nutritional changes during incretin-based therapy.Mizdrak et al.

Medical Sciences

The paper

Mizdrak M, Batistić D, Mizdrak I

Medical Sciences · 17 Sep 2026

doi.org/10.3390/medsci14050577PubMed 42783450

More on GLP-1 and incretin signalling